0001209191-19-018088.txt : 20190308
0001209191-19-018088.hdr.sgml : 20190308
20190308161339
ACCESSION NUMBER: 0001209191-19-018088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190306
FILED AS OF DATE: 20190308
DATE AS OF CHANGE: 20190308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mancilla Bethany
CENTRAL INDEX KEY: 0001748840
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 19669238
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-06
0
0001645460
Cue Biopharma, Inc.
CUE
0001748840
Mancilla Bethany
21 ERIE STREET
CAMBRIDGE
MA
02139
0
1
0
0
SVP and Chief Business Officer
Stock Option (right to buy)
6.42
2019-03-06
4
A
0
65000
0.00
A
2029-03-06
Common Stock
65000
65000
D
Stock Option (right to buy)
9.54
2019-03-06
4
A
0
100000
0.00
A
2025-08-01
Common Stock
100000
100000
D
This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019.
Represents a stock option award granted on August 1, 2018 that partially vested upon the achievement of certain performance based conditions as determined by the Compensation Committee of Cue Biopharma, Inc. on March 6, 2019. As of March 6, 2019, 50,000 of these options were vested and exercisable. The remaining 50,000 will become vested and exercisable only upon the achievement of certain performance based conditions.
/s/ Bethany Mancilla by Mark Busch, as attorney-in-fact
2019-03-08